Siga Technologies INC
$88.36M- Market cap
- $236.39M
- Debt
- +$6.94M
- Cash
- −$154.97M
Capital structure 97% equity / 3% debt · EV / Revenue 0.93x · EV / EBITDA 2.91x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: SIGA stock price vs MPW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MPW's multiple
Needs MPW P/E.
Implied fair value · at SIGA's multiple
Needs EPS (TTM) is negative, SIGA P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: SIGA FY 2025 (ended Dec 31, 2025) · MPW FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 97% equity / 3% debt · EV / Revenue 0.93x · EV / EBITDA 2.91x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Siga Technologies INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
MEDICAL PROPERTIES TRUST INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.03x
2.11x
Net debt / EBITDA
Leverage against operating earnings
-4.87x
33.67x
Cash and equivalents
Liquid reserves on the balance sheet
$154.97M
$540.86M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Emergent BioSolutions Inc.
SIGA vs EBS
BAXTER INTERNATIONAL INC
SIGA vs BAX
PERRIGO Co plc
SIGA vs PRGO
Moderna, Inc.
SIGA vs MRNA
Sabra Health Care REIT, Inc.
SIGA vs SBRA
WELLTOWER INC.
SIGA vs WELL
Ventas, Inc.
SIGA vs VTR
NATIONAL HEALTH INVESTORS INC
SIGA vs NHI
OMEGA HEALTHCARE INVESTORS INC
SIGA vs OHI
LTC PROPERTIES INC
SIGA vs LTC
$6.94M
$9.70B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.